Schiff Jonathan D, Luna Martha, Barritt Jason, Duke Marlena, Copperman Alan, Bar-Chama Natan
Department of Urology Mount Sinai School of Medicine, and Reproductive Medicine Associates of New York, New York, NY, USA.
BJU Int. 2007 Dec;100(6):1326-9. doi: 10.1111/j.1464-410X.2007.07187.x.
To investigate sperm morphology on the day of fresh testicular sperm extraction (TESE) with intracytoplasmic sperm injection (ICSI), and its effect on fertilization and pregnancy rates, as TESE in conjunction with ICSI results in high fertilization and pregnancy rates in most patients, but to our knowledge only one small study has assessed the morphology of retrieved sperm and found no correlation with the success of fertilization.
In a retrospective database analysis in a large academic centre, 68 men had 75 cycles of TESE combined with ICSI from January 2004 until April 2006. Sperm obtained by TESE was morphologically analysed at high (x 400-600) magnification and used for ICSI on the day of tissue retrieval. Sperm were classified as being either normal, having an amorphous head, having a mid-piece defect or having multiple defects. The calculated percentage of abnormal sperm injected was compared with the normal fertilization rate using Pearson's correlation coefficient, and pregnancy rates between groups were compared using chi-square analysis.
Fifteen cycles had all morphologically normal sperm; 21 cycles had 50-99% normal forms and 39 cycles had <50% normal sperm. There was a highly significant correlation between the percentage of normal sperm used for ICSI and fertilization rates (P = 0.007). Overall, 43 clinical pregnancies resulted in this series, i.e. three among the group with all normal sperm injected, 12 in the group with 50-99% normal sperm and 28 in the group with <50% normal forms. There were also 11 pregnancies in cycles that used no normal forms. Pregnancy rates did not differ significantly among the groups (P = 0.08).
TESE with ICSI frequently results in successful pregnancy; normal morphology was highly and significantly associated with successful fertilization, but importantly there were still 10 clinical pregnancies in cycles where only abnormal sperm were used. Sperm morphology after TESE should be assessed at the time of the procedure, and whenever possible, morphologically normal sperm chosen for injection. However, it is reassuring that acceptable fertilization and pregnancy rates are still achievable in cases with no morphologically normal sperm available.
在新鲜睾丸精子提取(TESE)联合卵胞浆内单精子注射(ICSI)当天研究精子形态,以及其对受精率和妊娠率的影响。因为TESE联合ICSI在大多数患者中能带来较高的受精率和妊娠率,但据我们所知,仅有一项小型研究评估了获取精子的形态,且未发现其与受精成功率相关。
在一家大型学术中心进行的回顾性数据库分析中,从2004年1月至2006年4月,68名男性进行了75个周期的TESE联合ICSI。通过TESE获取的精子在高倍(×400 - 600)放大倍数下进行形态学分析,并在组织获取当天用于ICSI。精子被分类为正常、头部无定形、中段缺陷或有多种缺陷。使用Pearson相关系数比较注射异常精子的计算百分比与正常受精率,并使用卡方分析比较各组之间的妊娠率。
15个周期的精子形态均正常;21个周期的正常形态精子占50 - 99%,39个周期的正常精子<50%。用于ICSI的正常精子百分比与受精率之间存在高度显著相关性(P = 0.007)。总体而言,该系列中有43例临床妊娠,即注射的精子全部正常的组中有3例,正常精子占50 - 99%的组中有12例,正常形态精子<50%的组中有28例。在未使用正常形态精子的周期中也有11例妊娠。各组之间的妊娠率无显著差异(P = 0.08)。
TESE联合ICSI经常能成功妊娠;正常形态与成功受精高度显著相关,但重要的是,在仅使用异常精子的周期中仍有10例临床妊娠。应在手术时评估TESE后的精子形态,并且只要有可能,选择形态正常的精子进行注射。然而,令人放心的是,在没有形态正常精子可用的情况下,仍可实现可接受的受精率和妊娠率。